RF - Intralesional 5-Fluorouracil in the Treatment of Nonmelanoma Skin Cancer

被引:3
作者
Gil-Lianes, J. [1 ]
Morgado-Carrasco, D. [1 ]
机构
[1] Univ Barcelona, Hosp Clin Barcelona, Serv Dermatol, Barcelona, Spain
来源
ACTAS DERMO-SIFILIOGRAFICAS | 2023年 / 114卷 / 03期
关键词
Basal cell carcinoma; Squamous cell carcinoma; Keratoacanthoma; 5-Fluorouracil; Intralesional;
D O I
10.1016/j.ad.2021.07.029
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
[No abstract available]
引用
收藏
页码:255 / 256
页数:2
相关论文
共 5 条
[1]   Topical and Intralesional Treatment of Nonmelanoma Skin Cancer: Efficacy and Cost Comparisons [J].
Chitwood, Katelyn ;
Etzkorn, Jeremy ;
Cohen, George .
DERMATOLOGIC SURGERY, 2013, 39 (09) :1306-1316
[2]  
Danesh MJ, 2021, J AM ACAD DERMATOL, V84, P1696, DOI [10.1016/j.jaad.2021.02.060, 10.1016/j.jaad.2020.12.049]
[3]   Intralesional chemotherapy for nonmelanoma skin cancer: A practical review [J].
Kirby, Joslyn S. ;
Miller, Christopher J. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 63 (04) :689-702
[4]  
Maghfour J, 2021, J DRUGS DERMATOL, V20, P192, DOI [10.36849/JDD.5518, 10.36849/JDD.2021.5518]
[5]   Intralesional 5-fluorouracil (FU) as a treatment for nonmelanoma skin cancer (NMSC): A review [J].
Metterle, Lauren ;
Nelson, Christopher ;
Patel, Nishit .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (03) :552-557